Understanding the mechanisms in accelerated drug reactions

Current Opinion in Allergy and Clinical Immunology

Volumn 16, Issue 4, 2016, Pages 308-314

  Torres, María J ^a   Salas, Maria ^a   Ariza, Adriana ^a   Fernández, Tahia D ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

accelerated reactions; drug hypersensitivity; IgE; T lymphocytes

Indexed keywords

CD69 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL9 CHEMOKINE; EPITOPE; GAMMA INTERFERON; HLA DR ANTIGEN; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 2 RECEPTOR ALPHA; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; IMMUNOGLOBULIN E; TUMOR NECROSIS FACTOR;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIGEN ANTIBODY COMPLEX; ARTHRALGIA; BIOTRANSFORMATION; CD4+ T LYMPHOCYTE; CELL HOMING; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DRUG HYPERSENSITIVITY; ERYTHROCYTE SEDIMENTATION RATE; HISTOPATHOLOGY; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOFLUORESCENCE TEST; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MACULOPAPULAR RASH; POLYARTHRITIS; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; PUBLICATION; RASH; REVIEW; SERUM SICKNESS; SKIN BIOPSY; SKIN TEST; URTICARIA; ANIMAL; CLASSIFICATION; IMMUNOLOGY; METABOLISM; TH1 CELL;

ANIMALS; CHEMOKINE CXCL9; DRUG HYPERSENSITIVITY; EXANTHEMA; HUMANS; IMMUNOGLOBULIN E; INTERFERON-GAMMA; RECEPTORS, CXCR3; SKIN TESTS; TH1 CELLS; TUMOR NECROSIS FACTOR-ALPHA; URTICARIA;

EID: 84973522281     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000285     Document Type: Review

References (47)

1. Organization WH. International drug monitoring: the role of national centres. Report of a WHO meeting. World Health Organ Tech Rep Ser 1972; 498: 1-25.
2. Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000; 356:1255-1259.
3. Thong BY, Leong KP, Tang CY, et al. Drug allergy in a general hospital: results of a novel prospective inpatient reporting system. Ann Allergy Asthma Immunol 2003; 90:342-347.
4. Rawlins MD, Thompson JW. Pathogenesis of adverse drug reactions. In: Davies DM, editor. Textbook of adverse drug reactions. Oxford: Oxford University Press; 1977.
5. Dona I, Blanca-Lopez N, Torres MJ, et al. Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol 2012; 22:363-371.
6. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004; 113:832-836.
7. Gomes ER, Demoly P. Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005; 5:309-316.
8. Gell PGH, Coombs RRA. Clinical aspects of immunology. Oxford: Blackwell; 1963.
9. Pichler WJ. Delayed drug hypersensitivity reactions. Ann Intern Med 2003; 139:683-693.
10. Levine BB. Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic diseases of man. N Engl J Med 1966; 275:1115-1125.
11. Terrados S, BlancaM, Garcia J, et al. Nonimmediate reactions to betalactams: prevalence and role of the different penicillins. Allergy 1995; 50:563-567.
12. Torres MJ, Blanca M, Fernandez J, et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58:961-972.
13. Romano A, Blanca M, Torres MJ, et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 2004; 59:1153-1160.
14. Bircher AJ, Scherer Hofmeier K. Drug hypersensitivity reactions: inconsistency in the use of the classification of immediate and nonimmediate reactions. J Allergy Clin Immunol 2012; 129:263-264.
15. Bircher AJ, Scherer K. Delayed cutaneous manifestations of drug hypersensitivity. Med Clin North Am 2010; 94:711-725. Demoly P, Adkinson NF, Brockow K, et al. International Consensus on drug allergy. Allergy 2014; 69:420-437.
16. Atanaskovic-Markovic M, Gaeta F, Medjo B, et al. Nonimmediate hypersensitivity reactions to beta-lactam antibiotics in children: our 10-year experience in allergy work-up. Pediatr Allergy Immunol 2016; DOI: 10. 1111/pai. 12565 [Epub ahead of print]
17. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report: second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117:391-397.
18. Limsuwan T, Demoly P. Acute symptoms of drug hypersensitivity (urticaria, angioedema, anaphylaxis, anaphylactic shock). Med Clin North Am 2010; 94:691-710.
19. Blanca-López N, Pérez-Sánchez N, Agúndez J, et al. Allergic reactions to metamizole: immediate and delayed responses. Int Arch Allergy Immunol 2016 (in press).
20. Torres MJ, Mayorga C, Leyva L, et al. Controlled administration of penicillin to patients with a positive history but negative skin and specific serum IgE tests. Clin Exp Allergy 2002; 32:270-276.
21. Christiansen IS, Kroigaard M, Mosbech H, et al. Clinical and diagnostic features of perioperative hypersensitivity to cefuroxime. Clin Exp Allergy 2015; 45:807-814.
22. Vial T, Pont J, Pham E, et al. Cefaclor-associated serum sickness-like disease: eight cases and review of the literature. Ann Pharmacother 1992; 26:910-914.
23. Hjortlund J, Mortz CG, Skov PS, et al. Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge. Allergy 2013; 68:1057-1064.
24. Bose S, Guyer A, Long A, et al. Evaluation and management of hypersensitivity to proton pump inhibitors. Ann Allergy Asthma Immunol 2013; 111:452-457.
25. Sobrevia Elfau MT, Garces Sotillos M, Ferrer Claveria L, et al. Study of crossreactivity between proton pump inhibitors. J Investig Allergol Clin Immunol 2010; 20:157-161.
26. Brockow K, Romano A, Aberer W, et al. Skin testing in patients with hypersensitivity reactions to iodinated contrast media: a European multicenter study. Allergy 2009; 64:234-241.
27. Warrington RJ, Silviu-Dan F, Magro C. Accelerated cell-mediated immune reactions in penicillin allergy. J Allergy Clin Immunol 1993; 92:626-628.
28. Torres MJ, Mayorga C, Fernandez TD, et al. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence. Int J Immunopathol Pharmacol 2006; 19:119-130.
29. Gomez E, Blanca-Lopez N, Salas M, et al. Induction of accelerated reactions to amoxicillin by T-cell effector mechanisms. Ann Allergy Asthma Immunol 2013; 110:267-273
30. Tolpinrud WL, Bunick CG, King BA. Serum sicknesselike reaction: histopathology and case report. J Am Acad Dermatol 2011; 65:e83-e85.
31. Aujero MP, Brooks S, Li N, et al. Severe serum sickness-like type III reaction to insulin detemir. J Am Acad Dermatol 2011; 64:e127-128.
32. Yerushalmi J, Zvulunov A, Halevy S. Serum sickness-like reactions. Cutis 2002; 69:395-397.
33. Swanson JK, English JC 3rd. Serum sickness-like reaction to pamabrom. J Drugs Dermatol 2006; 5:284-286.
34. Mathur AN, Mathes EF. Urticaria mimickers in children. Dermatol Ther 2013; 26:467-475.
35. Misirlioglu ED, Duman H, Ozmen S, et al. Serum sickness-like reaction in children due to cefditoren. Pediatr Dermatol 2012; 29:327-328.
36. Blanca-Lopez N, Zapatero L, Alonso E, et al. Skin testing and drug provocation in the diagnosis of nonimmediate reactions to aminopenicillins in children. Allergy 2009; 64:229-233.
37. Ponvert C, Perrin Y, Bados-Albiero A, et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol 2011; 22:411-418.
38. Zambonino MA, Corzo JL, Munoz C, et al. Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children. Pediatr Allergy Immunol 2014; 25:80-87
39. Gomes ER, Brockow K, Kuyucu S, et al. Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy 2016; 71:149-161.
40. Kearns GL, Wheeler JG, Childress SH, et al. Serum sickness-like reactions to cefaclor: role of hepatic metabolism and individual susceptibility. J Pediatr 1994; 125:805-811.
41. Hasdenteufel F, Waton J, Cordebar V, et al. Delayed hypersensitivity reactions caused by iodixanol: an assessment of cross-reactivity in 22 patients. J Allergy Clin Immunol 2011; 128:1356-1357.
42. Torres MJ, Gomez F, Dona I, et al. Diagnostic evaluation of patients with nonimmediate cutaneous hypersensitivity reactions to iodinated contrast media. Allergy 2012; 67:929-935.
43. Picker LJ, Treer JR, Ferguson-Darnell B, et al. Control of lymphocyte recirculation in man. II. Differential regulation of the cutaneous lymphocyte-associated antigen, a tissue-selective homing receptor for skin-homing T cells. J Immunol 1993; 150:1122-1136.
44. Blanca M, Torres MJ, Leyva L, et al. Expression of the skin-homing receptor in peripheral blood lymphocytes from subjects with nonimmediate cutaneousallergic drug reactions. Allergy 2000; 55:998-1004.
45. Fernandez TD, Mayorga C, Torres MJ, et al. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs. Allergy 2008; 63:712-719.
46. Ariza A, Barrionuevo E, Mayorga C, et al. IgE to penicillins with different specificities can be identified by a multiepitope macromolecule: bihaptenic penicillin structures andIgEspecificities. J ImmunolMethods2014;406:43-50.
47. Seitz CS, Brocker EB, Trautmann A. Diagnosis of drug hypersensitivity in children and adolescents: discrepancy between physician-based assessment and results of testing. Pediatr Allergy Immunol 2011; 22:405-410.